Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
International Journal of Biological Macromolecules|December 17, 2016
Broad substrate affinity and catalytic diversity of fibrinolytic enzyme from Pheretima posthumous-Purification and molecular characterization studyMahendra Kumar Verma, K K PulicherlaAmino Acids|January 8, 2016
Enzyme promiscuity in earthworm serine protease: substrate versatility and therapeutic potentialMahendra Kumar Verma, K K PulicherlaJournal of Food Science and Technology|September 8, 2015
Molecular insights into cold active polygalacturonase enzyme for its potential application in food processingL N Ramya, K K PulicherlaAAPS Pharmscitech|January 24, 2015
Targeting therapeutics across the blood brain barrier (BBB), prerequisite towards thrombolytic therapy for cerebrovascular disorders-an overview and advancementsK K Pulicherla, Mahendra Kumar VermaEnvironmental Research|October 25, 2021
Current efforts on sustainable green growth in the manufacturing sector to complement "make in India" for making "self-reliant India"K K Pulicherla, Vijayanand Adapa, Mrinmoy Ghosh, et al.International Journal of Biological Macromolecules|August 1, 2018
Perspectives on progressive strategies and recent trends in the production of recombinant human factor VIIIS T Mannully, Ramya L N, K K PulicherlaJournal of Immunoassay & Immunochemistry|December 18, 2015
Development and validation of an indirect competitive ELISA for quantification of recombinant staphylokinase in rabbit plasma: Application to pharmacokinetic studyAnmol Kumar, K K Pulicherla, K R S Sambasiva RaoJournal of Pediatric Hematology/Oncology|November 2, 2011
In silico engineering of L-asparaginase to have reduced glutaminase side activity for effective treatment of acute lymphoblastic leukemiaRamya Ln, Mukesh Doble, V P B Rekha, et al.Applied Biochemistry and Biotechnology|June 12, 2012
L-Asparaginase as potent anti-leukemic agent and its significance of having reduced glutaminase side activity for better treatment of acute lymphoblastic leukaemiaL N Ramya, Mukesh Doble, V P B Rekha, et al.Biologicals : Journal of the International Association of Biological Standardization|February 10, 2020
Purification and in vivo stability and half-life of recombinant lipid modified staphylokinaseSheethal Thomas Mannully, V P B Rekha, N Singh, et al.Pageof 2